Gastrointestinal Endoscopy Market

Report Description
Table of Contents

Report Description

The global gastrointestinal endoscopy market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Rising old-age population coupled with increasing gastrointestinal disorders is a key driver for the growth of the global gastrointestinal endoscopy market. Additionally, the increase in technologically advanced devices, government initiatives, increasing medical expenditure, and favourable medical reimbursements are some of the other drivers propelling the market growth. Nevertheless, the high cost of medical devices is expected to restrain the global market growth.

Global Ablation Technology Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is segmented into GI videoscopes, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopy, hemostatis devices, biopsy devices, and others. In 2021, the GI videoscopes segment accounted for the largest revenue share with lucrative CAGR during the forecast period. This is attributed to the escalating patient awareness for disease screening and increasing prevalence of gastrointestinal illness such as bowel syndrome, ulcer, & Crohn’s diseases worldwide. The other end-user segments include polypectomy snares, stents, oesophageal dilation balloons, enteral feeding devices, and anti-reflux devices.

By End-Use

Based on end-use, the market is categorized into clinics, hospitals, and others. The hospitals segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. The rising prevalence of patient admission coupled with modern screening infrastructure in hospitals are key factors that drive the segment growth. Clinics segment is projected to grow at a profitable CAGR during the forecast period. This is attributed to growing preference for speciality clinics due to better treatment and fear of cross infection during outbreak of covid19 pandemic.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of leading medical device companies, advanced healthcare infrastructure, and favorable medical reimbursement policies in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising incidences of gastrointestinal diseases, adoption of advanced diagnostics, and growing focus of medical device companies in this region.

Competitor Insights

Some of the key players in the gastrointestinal endoscopy market are Becton, Dickinson and Company (U.S.); Cook Group (U.S.); Fujifilm Holdings (Japan); Stryker Corporation (U.S.); Boston Scientific Corporation (U.S.); Johnson & Johnson (U.S.); Medtronic plc (Ireland); Conmed (U.S.); and B. Braun Holding GmbH & Co. KG (Germany). The leading players operating in the gastrointestinal endoscopy industry are adopting various strategies including R&D investments, novel product launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The gastrointestinal endoscopy market report is categorized into the following segments and subsegments: